Role of almitrine bismesylate in managing refractory hypoxemia in COVID19 acute respiratory distress syndrome
Main Authors: | Abhijit S Nair, Sai Kaushik Pulipaka, Poornachand Anne, Basanth Kumar Rayani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Saudi Journal of Anaesthesia |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2021;volume=15;issue=1;spage=76;epage=77;aulast=Nair |
Similar Items
-
The pharmacokinetics and metabolism of almitrine bismesylate
by: Gordon, Bentley Horatio
Published: (1995) -
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
by: François Bagate, et al.
Published: (2020-11-01) -
Anti-fibrotic drugs dealing with pulmonary fibrosis after COVID-19-associated acute respiratory distress syndrome
by: Abhijit S Nair, et al.
Published: (2021-01-01) -
Emergency management of refractory hypoxemia in mechanically ventilated patients with COVID-19 acute respiratory distress syndrome
by: Subash P Nandalan, et al.
Published: (2021-01-01) -
Acute gastric conduit dilatation after oesophagectomy as a cause of respiratory distress
by: Abhijit S Nair, et al.
Published: (2018-01-01)